TSE:BLUBELLUS Health Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BELLUS Health Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$14.18 -0.10 (-0.70 %) (As of 04/9/2020 04:36 AM ET) Add Compare Share Today's RangeC$14.05Now: C$14.18▼C$15.1850-Day RangeC$8.11MA: C$13.03▼C$15.9552-Week RangeC$3.30Now: C$14.18▼C$16.68Volume72,592 shsAverage Volume115,697 shsMarket CapitalizationC$852.91 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsInsider TradesHeadlinesSocial Media BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics for conditions with high unmet medical need. Its lead drug candidate includes BLU-5937, a small molecule antagonist of the P2X3 receptor for chronic cough. The company also has economic interests in various partnered development stage programs, including KIACTA for the treatment of sarcoidosis; AMO-01 for treatment of Phelan McDermid syndrome; and ALZ-801 for APOE4 homozygous Alzheimer's disease. BELLUS Health Inc. was founded in 1993 and is headquartered in Laval, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for BELLUS Health. Previous Next 2.4 Community Rank Outperform VotesBELLUS Health has received 113 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBELLUS Health has received 124 “underperform” votes. (Add your “underperform” vote.)Community SentimentBELLUS Health has received 52.32% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about BELLUS Health and other stocks. Vote “Outperform” if you believe BLU will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BLU will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldBELLUS Health does not currently pay a dividend.Dividend GrowthBELLUS Health does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BELLUS Health insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for BELLUS Health are expected to decrease by -100.00% in the coming year, from C($0.58) to C$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BELLUS Health is -19.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BELLUS Health is -19.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBELLUS Health has a P/B Ratio of 6.81. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange TSE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolTSE:BLU Previous Symbol CUSIPN/A CIKN/A Webhttp://www.bellushealth.com/ Phone+1-450-6804500Debt Debt-to-Equity Ratio0.21 Current Ratio12.38 Quick Ratio11.99Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$35,000.00 Price / Sales24,368.94 Cash FlowC$2.00 per share Price / Cash Flow7.10 Book ValueC$2.08 per share Price / Book6.81Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees10 Outstanding Shares60,149,000Market CapC$852.91 million Next Earnings Date5/13/2020 (Estimated) OptionableNot Optionable Receive BLU News and Ratings via Email Sign-up to receive the latest news and ratings for BLU and its competitors with MarketBeat's FREE daily newsletter. TSX:BLU Rates by TradingView BELLUS Health (TSE:BLU) Frequently Asked Questions How has BELLUS Health's stock been impacted by COVID-19 (Coronavirus)? BELLUS Health's stock was trading at C$13.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BLU shares have increased by 9.0% and is now trading at C$14.18. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of BELLUS Health? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BELLUS Health in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for BELLUS Health. When is BELLUS Health's next earnings date? BELLUS Health is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for BELLUS Health. How were BELLUS Health's earnings last quarter? BELLUS Health Inc (TSE:BLU) posted its quarterly earnings data on Thursday, February, 27th. The company reported ($0.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by $0.09. The firm had revenue of $0.01 million for the quarter, compared to analysts' expectations of $0.01 million. View BELLUS Health's earnings history. Has BELLUS Health been receiving favorable news coverage? Media stories about BLU stock have been trending very negative on Thursday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. BELLUS Health earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutBELLUS Health. Who are some of BELLUS Health's key competitors? Some companies that are related to BELLUS Health include BTG (BTG), MorphoSys (MOR), Vir Biotechnology (VIR), MorphoSys (MOR), Cronos Group (CRON), Abcam (ABC), Genus (GNS), Kodiak Sciences (KOD), Mesoblast (MSB), Concordia International (CXR), Polynovo (PNV), Clinuvel Pharmaceuticals (CUV), Oxford BioMedica (OXB), Trillium Therapeutics (TRIL) and Biotest (BIO). What other stocks do shareholders of BELLUS Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other BELLUS Health investors own include Emera (EMA), Zecotek Photonics (ZMS), GALAPAGOS NV/S (GLPG), Trade Desk (TTD), XCel Brands (XELB), AbbVie (ABBV), Canadian Imperial Bank of Commerce (CM), Omega Healthcare Investors (OHI), Air Canada (AC) and Aurora Cannabis (ACB). Who are BELLUS Health's key executives? BELLUS Health's management team includes the following people: Mr. Roberto Bellini, Pres, CEO & Director (Age 39)Mr. François Desjardins C.A., CPA, CPA, CA, VP of Fin. (Age 56)Dr. Denis Garceau, Sr. VP of Drug Devel. (Age 62)Mr. Tony Matzouranis, VP of Bus. Devel. (Age 46)Mr. Sébastien Roy, Corp. Sec. (Age 43) What is BELLUS Health's stock symbol? BELLUS Health trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BLU." How do I buy shares of BELLUS Health? Shares of BLU and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is BELLUS Health's stock price today? One share of BLU stock can currently be purchased for approximately C$14.18. How big of a company is BELLUS Health? BELLUS Health has a market capitalization of C$852.91 million and generates C$35,000.00 in revenue each year. BELLUS Health employs 10 workers across the globe. View additional information about BELLUS Health. What is BELLUS Health's official website? The official website for BELLUS Health is http://www.bellushealth.com/. How can I contact BELLUS Health? BELLUS Health's mailing address is 9-275 Armand-Frappier Blvd, LAVAL, QC H7V 4A7, Canada. The company can be reached via phone at +1-450-6804500. This page was last updated on 4/9/2020 by MarketBeat.com StaffFeatured Article: Why is the ROA ratio important?
